4.3 Article

Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism

期刊

JOURNAL OF NEUROIMMUNOLOGY
卷 193, 期 1-2, 页码 12-23

出版社

ELSEVIER
DOI: 10.1016/j.jneuroim.2007.07.025

关键词

stem cells; experimental autoimmune encephalomyelitis; indoleamine 2,3-dioxygenase; immunomodulation

资金

  1. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098, R01NS008952, P50NS011920, P01NS011920] Funding Source: NIH RePORTER
  2. NINDS NIH HHS [T32 NS007098, R01 NS008952-36, T32 NS007098-28, NS 07098, P50 NS011920-29, NS 08952, P50 NS011920, R01 NS008952, NS 11920] Funding Source: Medline

向作者/读者索取更多资源

Syngeneic, pluripotent Lin(-)Scal(+) bone marrow stem cells (SC), transferred to mice with experimental autoimmune encephalomyelitis, a model of multiple sclerosis, enhanced recovery, prevented relapses and promoted myelin repair. SC-treated mice showed elevated interferon-gamma production and induction of indoleamine 2,3 -dioxygenase (IDO) in CD11c(+) dendritic cells (DC). IDO induction was specific since in the presence of IDO-producing CD11c(+) DC, PLP stimulated T cell proliferation was inhibited and the IDO-inhibitor, 1-MT, abrogated the SC effect. Relapse prevention during chronic disease correlated with decreased responsiveness to PLP178-191 and MBP85-99. Thus, pluripotent SC induce IDO in DC leading to inhibition of antigen reactivity and spreading in EAE. (C) 206 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据